Level 2
Level 1

Cardiovascular (drug use)


38 words 0 ignored

Ready to learn       Ready to review

Ignore words

Check the boxes below to ignore/unignore words, then click save at the bottom. Ignored words will never appear in any learning session.

All None

Ignore?
Loop diuretics
heart failure (symptom control)
ACE inhibitors
heart failure (reduce mortality)
Angiotensin receptor blockers
heart failure (reduce mortality)
Beta blockers
heart failure (reduce mortality)
Aldosterone antagonists
heart failure (reduce mortality)
Cardiac glycoside
heart failure (symptom control)
Calcium channel blockers
avoid in heart failure
Alpha blockers
avoid in heart failure
NSAIDs
avoid in heart failure
High dose loop diuretic
acute pulmonary oedema
GTN spray
angina (symptom control)
Beta blockers
angina (symptom control)
Calcium channel blockers
angina (symptom control)
Long acting nitrate
angina (second line symptom control)
Statins
angina (cardioprotection)
Antiplatelets
angina (cardioprotection)
Antiplatelets (two)
post coronary stent implantation
ACE inhibitors or AR blockers
first line hypertension (if age <55)
Calcium channel blockers
first line hypertension (if age >55 or of afrocaribbean descent)
ACEI + CCB
second line hypertension
ACEI + CCB + thiazide-like diuretic
third line hypertension
ACEI + CCB + diuretic + [further diuretic or alpha or beta blocker]
fourth line hypertension
Methyldopa
hypertension in pregnancy
ACE inhibitors or AR blockers
hypertension in renal disease
Statins
hyperlipidaemia
Fibrates
hyperlipidaemia
Cholesterol absorption inhibitors
second line hyperlipidaemia
Amiodarone
tachycardia with adverse features
Amiodarone
tachycardia with broad QRS
Adenosine
regular tachycardia with narrow QRS
Beta blocker or calcium channel blocker
irregular tachycardia with narrow QRS
Muscarinic antagonist
bradycardia with adverse features
Beta agonists
second line bradycardia with adverse features
Flecainide
acute atrial fibrillation (structurally normal heart)
Amiodarone
acute atrial fibrillation (structural heart disease)
Beta blockers
atrial fibrillation (rate control, first line)
Cardiac glycoside
atrial fibrillation (rate control, second line)
Anticoagulants
atrial fibrillation (stroke prevention)